Investing
Top Analyst Upgrades and Downgrades (ACTV, AGN, BMY, CAG, COP, DUK, LLY, FRX, MRK, PFE, TIF, ULTA, WPI, YUM)
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Friday.
Active Network Inc. (NYSE: ACTV) raised to Buy at BofA/ML.
Allergan Inc. (NYSE: AGN) started as Buy at Citigroup.
Bristol-Myers Squibb Co. (NYSE: BMY) started as Neutral at Citigroup.
ConAgra Foods Inc. (NYSE: CAG) raised to Buy at Jefferies.
ConocoPhillips (NYSE: COP) started as Outperform at Wells Fargo.
Duke Energy Corp. (NYSE: DUK) maintained Outperform with $76.50 target at Credit Suisse.
Eli Lilly & Co. (NYSE: LLY) started as Buy at Citigroup.
Forest Laboratories Inc. (NYSE: FRX) started as Buy at Citigroup.
Merck & Co. (NYSE: MRK) started as Neutral at Citigroup.
Pfizer Inc. (NYSE: PFE) started as Buy at Citigroup.
Tiffany & Co. (NYSE: TIF) cut to Neutral at BofA/ML.
Ulta Salon Cosmetics & Fragrance Inc. (NASDAQ: ULTA) raised to Outperform at Wells Fargo.
Watson Pharmaceuticals Inc. (NYSE: WPI) reiterated Buy with $100 target and raised estimates at Argus.
Yum! Brands Inc. (NYSE: YUM) cut to Neutral at UBS and cut to Underperform at Raymond James.
JON C. OGG
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.